These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34607367)

  • 21. Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer.
    Kim HI; Kim TH; Kim H; Kim YN; Jang HW; Kim JH; Hur KY; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):286-291. PubMed ID: 28375573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
    Biondi B; Cooper DS
    Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
    Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
    Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
    Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
    Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
    J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma].
    Reverter JL; Colomé E
    Endocrinol Nutr; 2011 Feb; 58(2):75-83. PubMed ID: 21247815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.
    Glymph K; Gosmanov AR
    Endocr Pract; 2016 Jan; 22(1):22-9. PubMed ID: 26437220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine.
    Laugesen E; Moser E; Sikjaer T; Poulsen PL; Rejnmark L
    Thyroid; 2016 Jun; 26(6):779-84. PubMed ID: 27029953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer.
    Schumm MA; Lechner MG; Shu ML; Ochoa JE; Kim J; Tseng CH; Leung AM; Yeh MW
    Endocr Pract; 2021 Jul; 27(7):691-697. PubMed ID: 33642257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer.
    Liu C; Lv H; Li Q; Fu S; Tan J; Wang C; Wang X; Ma Y
    Medicine (Baltimore); 2020 Jul; 99(28):e21190. PubMed ID: 32664162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
    Fussey JM; Khan H; Ahsan F; Prashant R; Pettit L
    Head Neck; 2017 Dec; 39(12):2567-2572. PubMed ID: 28960722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment.
    Tagay S; Herpertz S; Langkafel M; Erim Y; Freudenberg L; Schöpper N; Bockisch A; Senf W; Görges R
    Eur J Endocrinol; 2005 Dec; 153(6):755-63. PubMed ID: 16322380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study.
    Fallahi P; Ragusa F; Patrizio A; Mazzi V; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Palmisano E; Cosenza MC; Varricchi G; Ulisse S; Benvenga S; Ferrari SM; Antonelli A
    Front Endocrinol (Lausanne); 2024; 15():1386629. PubMed ID: 39027476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
    Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
    Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
    Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.
    Klaver EI; van Loon HC; Stienstra R; Links TP; Keers JC; Kema IP; Kobold AC; van der Klauw MM; Wolffenbuttel BH
    Thyroid; 2013 Sep; 23(9):1066-73. PubMed ID: 23530992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
    Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
    Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.